Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities

Koyanagi, Satoru, Tanigawa, Noboru, Nakagawa, Hiroo, Soeda, Shinji, Shimeno, Hiroshi · 2003 · Biochemical Pharmacology

Abstract

Fucoidan, a sulfated polysaccharide extracted from brown seaweed, has anticoagulant and antithrombotic activities. Unlike heparin, it shows an inhibitory action on the progression and metastasis of malignant tumors, although the precise mechanisms have not been elucidated. We have demonstrated previously that fucoidan can inhibit tube formation following migration of human umbilical vein endothelial cells (HUVEC) and that its chemical oversulfation enhances the inhibitory potency. In this study, we tested the hypothesis that fucoidan may suppress tumor growth by inhibiting tumor-induced angiogenesis. Both natural and oversulfated fucoidans (NF and OSF) significantly suppressed the mitogenic and chemotactic actions of vascular endothelial growth factor 165 (VEGF(165)) on HUVEC by preventing the binding of VEGF(165) to its cell surface receptor. The suppressive effect of OSF was more potent than that of NF, suggesting an important role for the numbers of sulfate groups in the fucoidan molecule. Consistent with its inhibitory actions on VEGF(165), OSF clearly suppressed the neovascularization induced by Sarcoma 180 cells that had been implanted in mice. The inhibitory action of fucoidan was also observed in the growth of Lewis lung carcinoma and B16 melanoma in mice. These results indicate that the antitumor action of fucoidan is due, at least in part, to its anti-angiogenic potency and that increasing the number of sulfate groups in the fucoidan molecule contributes to the effe…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0006-2952(02)01478-8

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 27 references

Cited by

See all 479

Metadata

Authors
Koyanagi, S., Tanigawa, N., Nakagawa, H., Soeda, S., & Shimeno, H.
Affiliations
Fukuoka University (JP)
Corresponding author
Shimeno, Hiroshi
Venue
Biochemical Pharmacology
Publisher
Elsevier BV
Published
2003-01
Volume
65
Issue
2
Pages
173-179
ISSN
0006-2952 (ISSN-L)
OpenAlex
W2061760856
Cited by
479
References
27
Citations by year
2026: 10 · 2025: 11 · 2024: 10 · 2023: 18 · 2022: 23 · 2021: 24 · 2020: 33 · 2019: 31 · 2018: 24 · 2017: 21 · 2016: 16 · 2015: 29 · 2014: 28 · 2013: 34 · 2012: 26
FWCI
16.08
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Biochemical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Pharmacology (medical) › Fungal Biology and Applications
Keywords
fucoidan, sulfated polysaccharides, antiangiogenic activity, anticancer activity, VEGF165, VEGF receptor binding, endothelial tube formation, neovascularization, sarcoma 180, Lewis lung carcinoma, B16 melanoma, brown seaweed polysaccharides, sulfate groups
MeSH terms
Animals, Antineoplastic Agents, Cell Division, Cell Movement, Cells, Cultured, Disease Models, Animal, Endothelium, Vascular, Humans, Lymphokines, Melanoma, Experimental, Neoplasm Transplantation, Neovascularization, Pathologic, Phosphorylation, Polysaccharides, Sulfur, Endothelial Growth Factors, Angiogenesis Inhibitors, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. https://app.cochat.ai/papers/10.1016/s0006-2952(02)01478-8
The paper
Koyanagi, S., Tanigawa, N., Nakagawa, H., Soeda, S., & Shimeno, H. (2003). Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(02)01478-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.